Renault Shares: Stock Rebounds Ahead of 2025 Annual Results Release
Renault's stock is up 1.58% this Tuesday morning, trading at 32.81 euros on Euronext Paris. This upward movement comes as the automaker is set to publish its 2025 fiscal year results in two days, on February 19. Over the past week, the stock has gained 5.74%, amidst a marked decline over the year.
Current Market Position
Renault's stock price is currently below its main moving averages, indicating a persistently bearish trend. The 50-day moving average is at 33.99 euros and the 200-day at 36.41 euros, both well above the current price of 32.81 euros. This positioning reflects the stock's difficulty in reversing the negative momentum that has prevailed over the past year, with a 37.5% decline over twelve months. The Relative Strength Index (RSI) stands at 51, in a neutral zone, indicating no immediate directional pressure. However, the stock has recently crossed below its lower Bollinger band and is approaching the upper band (32.99 euros), suggesting that the current rebound might face resistance at this level. The most relevant support is at 30.54 euros, a level that has acted as a floor during recent consolidations.
Anticipation of 2025 Fiscal Year Results
Focus is now on the upcoming release of the 2025 fiscal year results, scheduled for Thursday, February 19. This event is the next major catalyst for the stock, following a third quarter of 2025 that already raised questions about the group's trajectory. The financial calendar then schedules the announcement of the first quarter revenue on April 23, followed by the annual general meeting of shareholders on April 30. Additionally, the group announced on Sunday the appointment of Grégoire de Franqueville as CEO of The Future is NEUTRAL, a joint venture created with SUEZ dedicated to circular economy in the automotive sector. This appointment, effective March 1, 2026, confirms the manufacturer's commitment to structuring its activities related to ecological transition. On the stock market, the quarterly performance remains negative, with a decline of 9.49% over three months, while the monthly volatility contained at 9.90% reflects moderate short-term fluctuation ranges.